Who has invested in Omega Therapeutics?

Flagship Pioneering are named among the investors backing Omega Therapeutics.

Omega Therapeutics Funding: $400M Raised, IPO (2021)

Omega Therapeutics funding overview

Omega Therapeutics is based in Cambridge, Massachusetts. Omega Therapeutics has raised $400M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in July 2021. The round record for Omega Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Flagship Pioneering.

Omega Therapeutics at a glance

Total raised: $400M
Latest round: IPO
Latest round date: July 2021
Headquarters: Cambridge, Massachusetts
Notable investors: Flagship Pioneering

Frequently asked about Omega Therapeutics funding

How much has Omega Therapeutics raised?: Omega Therapeutics has raised $400M in total disclosed funding across the rounds on record.
Who has invested in Omega Therapeutics?: Flagship Pioneering are named among the investors backing Omega Therapeutics.
What was the latest Omega Therapeutics funding round?: The most recent disclosed round is an IPO, announced in July 2021.
Where is Omega Therapeutics based?: Omega Therapeutics is based in Cambridge, Massachusetts.
When did Omega Therapeutics last raise?: The last disclosed Omega Therapeutics round closed in July 2021 at IPO.

We update the Omega Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.

Omega Therapeutics Funding: $400M Raised, IPO (2021)

Omega Therapeutics funding overview

Omega Therapeutics at a glance

Frequently asked about Omega Therapeutics funding

Companies related to Omega Therapeutics (36)

Browse related funding lists (6)